The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Gray. Purple. Brown. Scales and skin flakes caused by plaque psoriasis are usually silver on darker skin tones. Will Scalp Psoriasis Affect My Hair Growth? Plaques can develop on your scalp and ...

That's where a salicylic acid shampoo comes in. Like a dandruff shampoo, these formulas can help relieve dryness, flakes, and ...

Discover why your skin develops scaling patches, from common dry skin to medical conditions requiring treatment, plus ...

Salt water may help exfoliate facial skin and treat certain skin diseases. Learn the science behind what it does and does not ...

J&J announces positive data from phase 3 ICONIC-TOTALa study of icotrokinra to treat scalp and genital psoriasis: Spring House, Pennsylvania Monday, May 12, 2025, 11:00 Hrs [IST] ...

66% of patients with scalp psoriasis and 77% with genital psoriasis ... and foot psoriasis using a 5-point scale to score the plaques on the hands and feet as: clear (0), almost clear (1), mild (2), ...

66% of patients with scalp psoriasis and 77% with ... using a 5-point scale to score the plaques on the hands and feet as: clear (0), almost clear (1), mild (2), moderate (3) and severe (4).